InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-10-03 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2025-09-22 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2025-08-08 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2025-07-07 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2025-06-16 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
No financial data available for INSM.
Company may not file with SEC or CIK is unresolved.
Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026
William Blair updates conviction stock list
Raymond James Starts Insmed (INSM) at Outperform, Citing Limited Competition
Vanguard’s Larger Passive Stake Puts Insmed’s Volatile Story In Focus
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates
Insmed to Present at May 2026 Investor Conferences
Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models
How The Insmed (INSM) Investment Story Is Shifting On Brinsupri And ENCORE Developments
Nasdaq hits record high after Iran opens Strait of Hormuz
Goldman rebalances its long duration stock basket
Insmed drops skin disorder candidate after mid-stage trial setback